1. Home
  2. VICR vs SNDX Comparison

VICR vs SNDX Comparison

Compare VICR & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VICR
  • SNDX
  • Stock Information
  • Founded
  • VICR 1981
  • SNDX 2005
  • Country
  • VICR United States
  • SNDX United States
  • Employees
  • VICR N/A
  • SNDX N/A
  • Industry
  • VICR Industrial Machinery/Components
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VICR Technology
  • SNDX Health Care
  • Exchange
  • VICR Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • VICR 1.6B
  • SNDX 1.6B
  • IPO Year
  • VICR N/A
  • SNDX 2016
  • Fundamental
  • Price
  • VICR $55.30
  • SNDX $16.09
  • Analyst Decision
  • VICR Hold
  • SNDX Strong Buy
  • Analyst Count
  • VICR 2
  • SNDX 11
  • Target Price
  • VICR $43.00
  • SNDX $37.18
  • AVG Volume (30 Days)
  • VICR 315.6K
  • SNDX 2.2M
  • Earning Date
  • VICR 10-22-2024
  • SNDX 11-05-2024
  • Dividend Yield
  • VICR N/A
  • SNDX N/A
  • EPS Growth
  • VICR N/A
  • SNDX N/A
  • EPS
  • VICR 0.10
  • SNDX N/A
  • Revenue
  • VICR $355,544,000.00
  • SNDX $16,000,000.00
  • Revenue This Year
  • VICR N/A
  • SNDX N/A
  • Revenue Next Year
  • VICR $10.70
  • SNDX $219.92
  • P/E Ratio
  • VICR $548.43
  • SNDX N/A
  • Revenue Growth
  • VICR N/A
  • SNDX N/A
  • 52 Week Low
  • VICR $30.90
  • SNDX $15.00
  • 52 Week High
  • VICR $61.05
  • SNDX $25.34
  • Technical
  • Relative Strength Index (RSI)
  • VICR 61.48
  • SNDX 37.58
  • Support Level
  • VICR $51.07
  • SNDX $15.00
  • Resistance Level
  • VICR $54.08
  • SNDX $16.27
  • Average True Range (ATR)
  • VICR 2.74
  • SNDX 1.08
  • MACD
  • VICR -0.48
  • SNDX -0.36
  • Stochastic Oscillator
  • VICR 60.32
  • SNDX 14.53

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, advanced power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. Geographically, it derives a maximum of its revenue from the Asia Pacific.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Share on Social Networks: